Have a personal or library account? Click to login
A preliminary report on the susceptibility to aminoglycosides of Escherichia coli isolated from the community-acquired urinary tract infections in adults in south-east Poland Cover

A preliminary report on the susceptibility to aminoglycosides of Escherichia coli isolated from the community-acquired urinary tract infections in adults in south-east Poland

Open Access
|May 2015

References

  1. 1. Alberici I. et al.: Pathogens causing urinary tract infections in infants: A European overview by the ESCAPE study group. Eur. J. Pediatr., 2014.10.1007/s00431-014-2459-325428232
  2. 2. Bien J. et al.: Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol., 2012, Article ID 681473, 2012. doi: 10.1155/2012/68147310.1155/2012/681473331227922506110
  3. 3. Firoozeh F. et al.: Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int. J. Infect. Dis., 219, 29, 2014.10.1016/j.ijid.2014.03.139325449257
  4. 4. Gupta K. et al.: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis., e103, 52, 2011.
  5. 5. Hsueh P.R. et al.: Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J. Infect., 114, 63, 2011.10.1016/j.jinf.2011.05.01521669223
  6. 6. Huang L.F. et al.: Antimicrobial susceptibility patterns among Escherichia coli urinary isolates from community-onset health care-associated urinary tract infection. J. Form. Med. Assoc., 970, 113, 2014.10.1016/j.jfma.2014.01.00924548621
  7. 7. Ironmonger D. et al.: Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years J. Antimicrob. Chemother., 2015.10.1093/jac/dkv04325733586
  8. 8. Jacskon J. et al.: Aminoglycosides: How should we use them in the 21st century? Curr. Opin. Infect. Dis., 516, 26, 2013.10.1097/QCO.000000000000001224141453
  9. 9. Jafri S.A. et al.: Antibiotic resistance of E. coli isolates from urine samples of urinary tract infection (UTI) patients in Pakistan. Bioinformation, 419, 10, 2014.10.6026/97320630010419413528925187681
  10. 10. Lai B. et al.: In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: A 9-year surveillance study (2004-2012). BMC Infect. Dis., 66, 14, 2014.10.1186/1471-2334-14-66392250524502648
  11. 11. Leclercq R. et al.: EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect., 141, 19, 2013.10.1111/j.1469-0691.2011.03703.x22117544
  12. 12. Udo E.E., Dashti A.A.: Detection of genes encoding aminoglycoside modifying enzymes in Staphylococci by polymerase chain reaction and dot blot hybridization. Int. J. Antimicrob. Agents, 273, 13, 2000.
  13. 13. Soleimani N. et al.: Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from a Iranian hospital. BMC Res. Notes, 842, 7, 2014.10.1186/1756-0500-7-842425824925424607
  14. 14. Sorlozano A. et al.: Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study. Am. J. Infect. Control, 1033, 42, 2014.10.1016/j.ajic.2014.06.01325278389
  15. 15. www.eucast.org
DOI: https://doi.org/10.1515/cipms-2015-0037 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 27 - 29
Submitted on: Mar 2, 2015
|
Accepted on: Mar 18, 2015
|
Published on: May 9, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Magdalena Fidecka-Skwarzynska, Marek Juda, Lucyna Maziarczyk, Anna Malm, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.